EDP Sciences logo
Subscriber Authentication Point
Search
Menu
Home All issues Volume 20 / No 3 (Mars 2004) Med Sci (Paris), 20 3 (2004) 325-330 References
Free Access
Issue
Med Sci (Paris)
Volume 20, Number 3, Mars 2004
Page(s) 325 - 330
Section M/S revues
DOI https://doi.org/10.1051/medsci/2004203325
Published online 15 March 2004
  1. Hsich G, Sena-Esteves M, Breakefield XO. Critical issues in gene therapy for neurologic disease. Hum Gene Ther 2002; 13 : 579–604. [Google Scholar]
  2. Pohl M, Braz J. Gene therapy of pain : emerging strategies and future directions. Eur J Pharmacol 2001; 429 : 39–48. [Google Scholar]
  3. Wu CL, Garry MG, Zollo RA, Yang J. Gene therapy for the management of pain. Anesthesiology 2001; 94 : 1119–32. [Google Scholar]
  4. Lin CR, Yang LC, Lee TH, et al. Electroporation-mediated pain-killer gene therapy for mononeuropathic rats. Gene Ther 2002; 9 : 1247–53. [Google Scholar]
  5. Finegold AA, Mannes AJ, Iadarola MI. A paracrine paradigm for in vivo gene therapy in the central nervous system : treatment of chronic pain. Hum Gene Ther 1999; 10 : 1251–7. [Google Scholar]
  6. Wilson SP, Yeomans DC, Bender MA, et al. Antihyperalgesic effects of infection with a preproenkephalin-encoding herpes virus. Proc Natl Acad Sci USA 1999; 96 : 3211–6. [Google Scholar]
  7. Goss JR, Mata M, Goins WF, et al. Antinociceptive effect of a genomic herpes simplex virus-based vector expressing human proenkephalin in rat dorsal root ganglion. Gene Ther 2001; 8 : 551–6. [Google Scholar]
  8. Hao S, Mata M, Goins W, et al. Transgene mediated enkephalin release enhances the effect of morphine and evades tolerance to produce a sustained antiallodynic effect in neuropathic pain. Pain 2003; 102 : 135–42. [Google Scholar]
  9. Goss JR, Harley CF, Mata M, et al. Herpes vector-mediated expression of proenkephalin reduces bone cancer pain. Ann Neurol 2002; 52 : 662–5. [Google Scholar]
  10. Antunes Bras JM, Epstein AE, Bourgoin S, et al. Herpes simplex virus 1-mediated transfer of preproenkephalin A in rat dorsal root ganglia. J Neurochem 1998; 70 : 1299–303. [Google Scholar]
  11. Braz J, Beaufour C, Coutaux A, et al. Therapeutic efficacy in experimental polyarthritis of viral-driven enkephalin overproduction in sensory neurons. J Neurosci 2001; 21 : 7881–8. [Google Scholar]
  12. Braz J, Meunier A, Beaufour C, et al. Therapeutic efficacy in experimental polyarthritis of viral-driven enkephalin overproduction in sensory neurons. In : Dostrovsky JO, Carr DB, Kotzenburg M, eds. Proceedings of the 10th World congress on pain. Seattle : IASP Press, 2003 : 960 p. [Google Scholar]
  13. Takeba Y, Suzuki N, Kaneko A, et al. Endorphin and enkephalin ameliorate excessive synovial cell functions in patients with rheumatoid arthritis. J Rheumatol 2001; 28 : 2176–83. [Google Scholar]
  14. Oprée A, Kress M. Involvement of the proinflammatory cytokines tumor necrosis factor-a, IL-1b, and IL-6 but not IL-8 in the development of heat hyperalgesia : effects on heat-evoked calcitonin gene-related peptide release from rat skin. J Neurosci 2001; 20 : 6289–93. [Google Scholar]
  15. Inoue A, Ikoma K, Morioka N, et al. Interleukin-1beta induces substance P release from primary afferent neurons through the cyclooxygenase-2 system. J Neurochem 1999; 73 : 2206–13. [Google Scholar]
  16. Junker U, Böhnlein E. Gene therapy for arthritis 1996-1999. Exp Opin Ther Patents 1999; 9 : 1491–8. [Google Scholar]
  17. Watkins LR, Milligan ED, Maier SF. Glial activation : a driving force for pathological pain. Trends Neurosci 2001; 24 : 450–5. [Google Scholar]
  18. Fernandes JC, Martel-Pelletier J, Pelletier JP. Gene therapy for osteoarthritis. Clin Orthop 2000; 379 (suppl) : S262–72. [Google Scholar]
  19. Wagner R, Janjigian M, Myers RR. Anti-inflammatory interleukin-10 therapy in CCI neuropathy decreases thermal hyperalgesia, macrophage recruitment, and endoneurial TNF-a expression. Pain 1998; 74 : 35–42. [Google Scholar]
  20. Cunha FQ, Poole S, Lorenzetti BB, et al. Cytokine-mediated inflammatory hyperalgesia limited by interleukin-4. Br J Pharmacol 1999; 126 : 45–50. [Google Scholar]
  21. Yao MZ, Gu JF, Wang JH, et al. Interleukin-2 gene therapy of chronic neuropathic pain. Neuroscience 2002; 112 : 409–16. [Google Scholar]
  22. Milligan ED, O’Connor KA, Hamack SE, et al. A novel gene therapy approach for controlling pathological pain states : intrathecal delivery in rats of viral vectors encoding the anti-inflammatory cytokine, interleukin-10. Proceedings of the 10th World congress on pain. Seattle : IASP Press, 2002; 135 (abstract 392-P26). [Google Scholar]
  23. Lu CY, Chou AK, Wu CH, et al. Gene-gun particle with pro-opiomelanocortin cDNA produces analgesia against formalin-induced pain in rats. Gen Ther 2002; 9 : 1008–14. [Google Scholar]
  24. Eaton MJ, Blits B, Ruitenberg MJ, et al. Amelioration of chronic neuropathic pain after partial nerve injury by adeno-associated viral (AAV) vector-mediated over-expression of BDNF in the rat spinal cord. Gen Ther 2002; 9 : 1387–95. [Google Scholar]

Current usage metrics show cumulative count of Article Views (full-text article views including HTML views, PDF and ePub downloads, according to the available data) and Abstracts Views on Vision4Press platform.

Data correspond to usage on the plateform after 2015. The current usage metrics is available 48-96 hours after online publication and is updated daily on week days.

Initial download of the metrics may take a while.